Higher doses of radiotherapy cut treatment time by up to 75 per cent in localised prostate cancer patients, while maintaining high cure rates 29 Sep 2023 People with low to medium-risk, localised prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, according to researchers from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. Find out more Show/Hide
Biological markers identified as powerful predictors of prostate cancer relapse following radiotherapy 04 Apr 2023 Two key proteins linked to cell division can reliably predict disease recurrence in prostate cancer after radiotherapy treatment, according to new research. Find out more Show/Hide
Advanced radiotherapy safely treats prostate cancer patients in a quarter of the time of current standard 09 Nov 2022 An advanced radiotherapy technique can be used to safely treat prostate cancer patients in as little as one to two weeks, compared with the current standard, which takes one to two months. Find out more Show/Hide
Shorter radiotherapy courses for prostate cancer are well tolerated long-term by patients 19 Sep 2021
MRI data can predict patient response to treatment and survival in advanced ovarian cancer 30 Jan 2020